POU6F2

POU class 6 homeobox 2, the group of POU class homeoboxes and pseudogenes

Basic information

Region (hg38): 7:38977909-39493095

Links

ENSG00000106536NCBI:11281OMIM:609062HGNC:21694Uniprot:P78424AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Wilms tumor 5 (Limited), mode of inheritance: Unknown

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Wilms tumor 5ADOncologicIndividuals may be at high risk for Wilms tumor, and surveillance may allow early diagnosis and treatmentOncologic11284034
Germline variants can predispose to disease due to loss of heterozygosity

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the POU6F2 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the POU6F2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
14
clinvar
3
clinvar
17
missense
45
clinvar
6
clinvar
5
clinvar
56
nonsense
0
start loss
0
frameshift
0
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
0
splice region
1
2
3
non coding
0
Total 0 0 45 20 9

Variants in POU6F2

This is a list of pathogenic ClinVar variants found in the POU6F2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
7-38978015-C-G Wilms tumor 5 Pathogenic (Nov 01, 2004)1872
7-39085873-C-A not specified Uncertain significance (Aug 12, 2021)2243351
7-39085895-G-A Likely benign (Nov 03, 2018)755796
7-39085902-G-C not specified Uncertain significance (Mar 30, 2024)3309064
7-39085951-C-T not specified Uncertain significance (Jun 18, 2021)2233435
7-39085960-G-A not specified Uncertain significance (Mar 30, 2024)3309063
7-39086030-C-T Likely benign (Dec 31, 2019)793351
7-39204240-A-G not specified Uncertain significance (Jan 20, 2023)2471806
7-39204265-C-T Hypogonadotropic hypogonadism Uncertain significance (-)2499167
7-39204282-C-A not specified Uncertain significance (Feb 06, 2024)3216994
7-39204305-C-G Likely benign (Dec 31, 2019)717220
7-39204319-G-A Hypogonadotropic hypogonadism • not specified Uncertain significance (Jun 29, 2023)2499166
7-39207416-G-T not specified Uncertain significance (Feb 13, 2024)3216995
7-39207426-T-C not specified Uncertain significance (Dec 06, 2021)2226050
7-39207431-G-A not specified Uncertain significance (Dec 11, 2023)3216996
7-39207456-C-T not specified Uncertain significance (Sep 01, 2021)2247828
7-39207462-A-G Hypogonadotropic hypogonadism Uncertain significance (-)2573999
7-39207475-C-T Likely benign (Mar 29, 2018)739065
7-39207519-T-C not specified Uncertain significance (May 01, 2024)3309066
7-39339681-T-A POU6F2-related disorder Likely benign (May 04, 2023)3057617
7-39339681-T-G POU6F2-related disorder Likely benign (Oct 17, 2018)713595
7-39339682-C-G POU6F2-related disorder Likely benign (May 04, 2023)3046941
7-39339687-T-A Likely benign (Oct 17, 2018)713596
7-39339688-C-G Likely benign (Oct 17, 2018)713597
7-39339688-CCAG-C POU6F2-related disorder Benign (May 02, 2019)3060981

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
POU6F2protein_codingprotein_codingENST00000403058 10515097
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.001520.99812536112471256090.000988
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.4553613860.9350.00002184427
Missense in Polyphen5253.5910.97031578
Synonymous-0.2201741701.020.00001071470
Loss of Function3.521132.70.3360.00000165317

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0007350.000735
Ashkenazi Jewish0.001350.000695
East Asian0.0001110.000109
Finnish0.003010.00111
European (Non-Finnish)0.0008370.000520
Middle Eastern0.0001110.000109
South Asian0.008260.00445
Other0.002030.000979

dbNSFP

Source: dbNSFP

Function
FUNCTION: Probable transcription factor likely to be involved in early steps in the differentiation of amacrine and ganglion cells. Recognizes and binds to the DNA sequence 5'-ATGCAAAT-3'. Isoform 1 does not bind DNA.;

Recessive Scores

pRec
0.135

Intolerance Scores

loftool
0.110
rvis_EVS
-0.55
rvis_percentile_EVS
19.93

Haploinsufficiency Scores

pHI
0.818
hipred
N
hipred_score
0.492
ghis
0.412

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.207

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumHigh
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Pou6f2
Phenotype
normal phenotype;

Gene ontology

Biological process
regulation of transcription, DNA-templated;regulation of transcription by RNA polymerase II;transcription by RNA polymerase II;ganglion mother cell fate determination;central nervous system development;visual perception
Cellular component
nucleus
Molecular function
DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity